Quick Answer
Citius Pharmaceuticals, Inc. reported Research And Development Expense of $9.16 million for the year ending 2025.
- Citius Pharmaceuticals, Inc. showed a decrease of -23.1% in Research And Development Expense from 2024 to 2025.
- This data is from Citius Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Citius Pharmaceuticals, Inc.'s Research And Development Expense has grown by 1,760.6%.
- Historical annual values: Fiscal year 2025: $9.16 million | Fiscal year 2024: $11.91 million | Fiscal year 2023: $14.82 million | Fiscal year 2022: $17.66 million | Fiscal year 2021: $12.24 million | Fiscal year 2020: $8.81 million | Fiscal year 2019: $8.60 million | Fiscal year 2018: $6.56 million | Fiscal year 2017: $2.94 million | Fiscal year 2016: $2.93 million | Fiscal year 2015: $1.80 million | Fiscal year 2014: $574.00 | Fiscal year 2013: $492.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: